Intervention group (n= 17) | Control group (n= 29) | Pvalue | |
---|---|---|---|
Age (years) | 63 (46 to 75) | 66 (39 to 85) | 0.340 |
Gender (female) | 5 (30%) | 10 (34%) | 0.999 |
Hospital stay (mean, days) | 32 (9 to 118) | 31 (3 to 112) | 0.632 |
APACHE II (mean) | 17 (8 to 29) | 17 (8 to 29) | 0.730 |
Ejection fraction <40% | 8 (47%) | 17 (58%) | 0.545 |
Receiving antibiotics prior to study | 11 (65%) | 11 (38%) | 0.126 |
Septic shock | 9 (53%) | 16 (55%) | 0.999 |
Patients with adjustment therapy based on SeptiFast® | 6 (35%) | - | |
Patients with adjustment therapy based on blood culture | - | 7 (21%) | |
Mean time (minutes) of adjustment therapy | 580 | 3,007 | 0.004 |
Pathogens detected in SeptiFast® | P. aeruginosa (2), K. pneumonia/oxytoca (1), E. aerogenes/cloacae (1), S. marcescens (1), A. baumanii (1) | - | |
Pathogens detected in blood culture | - | S. aureus (4), K. pneumonia (2), M. morganii (1) | |
28-day mortality | 9 (53%) | 17 (59%) | 0.765 |